Health Economic Modeling for Payer and Hospital Decisions

Regulatory approval addresses whether a product can be marketed, while payer and hospital decisions also depend on evidence of clinical value, economic impact, and implementation considerations.
Health economic evidence helps connect clinical performance to the financial and operational questions that payers, hospitals, and other decision-makers use to assess value.
Early health economic models can help to identify key value drivers, map out key segments of the population that will benefit most from your technology or program, and bring focus to your strategic plan.

Health economic modeling can be performed from different perspectives and can answer different questions depending on the decision-maker, population, comparator, time horizon, and available evidence.
Depending on the decision, models may be used to estimate budget impact, cost-effectiveness, cost-benefit, revenue implications, pricing scenarios, or the consequences of alternative adoption pathways.
The way that you present the results of your health economic analysis (the robustness of your model) is equally as important as the validity of your findings; interactive health economic models can improve communication of your technology’s value story.

Following a three-phased approach, our experts can perform health economic modeling – from basic decision tree and Markov models through the most complex discrete event simulations, with analyses that may include budget impact, revenue generation, cost-effectiveness, and cost-benefit approaches. The model is structured around the decision context and can incorporate objectives such as improving patient outcomes, improving the patient experience of care, supporting providers, and reducing costs from the payer or facility perspective.
Our models are validated and parameterized through in-depth review of literature, consultation with expert panels, and derivation of data from supplemental sources.
With our advanced modeling capabilities and software, we can transform complex health economic models into interactive sales tools allowing your stakeholders to view details on costs and benefits, as well as graphical summaries of benefits, and perform live, interactive statistical calculations to fully understand the potential value of your technology and make data-driven decisions.

Insights

TTi Health Research & Economics2026-08-10T12:43:41-04:00August 10, 2026|Blog, Featured|

One Study Is Not an Evidence Strategy: Why MedTech Companies Need an Evidence Roadmap [...]

Why Good Clinical Data Still Fails to Win Coverage One of the hardest [...]

Why Founders Underestimate Protocol Design One of the first questions I ask founders [...]